• LAST PRICE
    3.7700
  • TODAY'S CHANGE (%)
    Trending Down-0.2600 (-6.4516%)
  • Bid / Lots
    2.4300/ 1
  • Ask / Lots
    4.2000/ 5
  • Open / Previous Close
    4.0300 / 4.0300
  • Day Range
    Low 3.7500
    High 4.0300
  • 52 Week Range
    Low 1.9400
    High 8.3100
  • Volume
    120,035
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 4.03
TimeVolumeDSGN
09:32 ET58113.98
09:34 ET35253.87
09:36 ET30113.91
09:38 ET1003.91
09:39 ET1003.895
09:41 ET3683.92
09:43 ET1003.92
09:50 ET4133.93
09:52 ET6003.93
09:54 ET28183.93
10:10 ET1803.93
10:14 ET14033.935
10:19 ET19823.965
10:21 ET13003.94
10:26 ET2003.94
10:32 ET12143.93
10:33 ET7003.93
10:42 ET3003.93
10:44 ET9003.91
10:48 ET8543.92
10:51 ET7063.92
10:57 ET1063.92
11:13 ET1003.92
11:20 ET6003.935
11:40 ET7003.97
11:42 ET1003.97
11:45 ET1013.97
12:02 ET1003.97
12:03 ET8003.97
12:07 ET2003.98
12:09 ET1003.97
12:12 ET1003.97
12:25 ET2003.975
12:30 ET5003.96
12:32 ET3003.95
12:41 ET6003.93
12:43 ET3003.925
12:45 ET1003.93
12:56 ET2003.925
12:59 ET4003.9225
01:08 ET1003.925
01:15 ET2003.93
01:17 ET4003.93
01:24 ET1193.95
01:30 ET2003.95
01:32 ET1003.95
01:46 ET1003.95
01:48 ET21503.959
01:50 ET59423.96
01:51 ET7003.955
01:57 ET15443.94
02:02 ET29423.88
02:08 ET1003.88
02:11 ET1003.88
02:15 ET5663.875
02:18 ET20123.8968
02:22 ET1003.9
02:29 ET23593.885
02:31 ET34773.87
02:45 ET2003.85
02:51 ET13443.845
02:56 ET1003.83
02:58 ET2683.83
03:02 ET9133.85
03:18 ET18623.85
03:21 ET5153.84
03:23 ET1003.84
03:25 ET6563.81
03:30 ET10003.77
03:36 ET1003.76
03:38 ET1003.75
03:41 ET10743.76
03:45 ET3003.765
03:48 ET1003.765
03:50 ET8003.78
03:52 ET1003.78
03:54 ET1003.785
03:56 ET1003.785
03:57 ET1003.785
03:59 ET16643.77
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesDSGN
Design Therapeutics Inc
214.7M
-3.6x
---
United StatesPRLD
Prelude Therapeutics Inc
217.5M
-2.1x
---
United StatesRZLT
Rezolute Inc
218.3M
-4.8x
---
United StatesOPT
Opthea Ltd
211.6M
-1.0x
---
United StatesRENB
Renovaro Inc
219.8M
-1.9x
---
United StatesRANI
Rani Therapeutics Holdings Inc
209.2M
-3.1x
---
As of 2024-06-12

Company Information

Design Therapeutics, Inc. is a biotechnology company. It is engaged in the research and development of GeneTACT molecules, which are small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its Friedreich ataxia (FA) program is focused on the development of a disease-modifying treatment. Its DT-216 is developed to overcome the FXN transcription impairment that causes FA. DT-216 is in Phase I clinical trial. The Company is also engaged in developing DT-216 to enable higher exposure and chronic administration for treatment of FA, known as DT-216P2, which uses the same drug substance, DT-216. Its FECD program is focused on the development of a potentially disease-modifying medical treatment for FECD, DT-168, which is in Phase I clinical trial. Its HD program is focused on the development of a potentially disease-modifying treatment for HD.

Contact Information

Headquarters
6005 Hidden Valley Road, Suite 110CARLSBAD, CA, United States 92011
Phone
858-293-4900
Fax
302-636-5454

Executives

Chairman of the Board, President, Chief Executive Officer, Principal Financial Officer
Pratik Shah
Chief Operating Officer
Sean Jeffries
Chief Medical Officer
Jae Kim
Lead Independent Director
Simeon George
Independent Director
Heather Berger

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$214.7M
Revenue (TTM)
$0.00
Shares Outstanding
56.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.05
Book Value
$4.92
P/E Ratio
-3.6x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.